OPEN END TURBO LONG - MERCK & CO. Stock

Certificat

DE000MD5M4E8

Real-time Bid/Ask 08:01:18 2024-07-08 EDT
3.24 EUR / 3.28 EUR +2.84% Intraday chart for OPEN END TURBO LONG - MERCK & CO.
Current month-5.65%
1 month-10.20%
Date Price Change
24-07-08 3.23 +1.89%
24-07-05 3.17 +2.92%
24-07-04 3.08 -2.22%
24-07-03 3.15 -6.53%
24-07-02 3.37 -1.46%

Delayed Quote Börse Stuttgart

Last update July 08, 2024 at 06:47 am

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MD5M4E
ISINDE000MD5M4E8
Date issued 2022-06-27
Strike 91.82 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.12
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 3.95
Lowest since issue 0.41
Spread 0.05
Spread %1.52%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
126.4 USD
Average target price
142.7 USD
Spread / Average Target
+12.84%
Consensus